Faculty:

Gregory P. Fontana, MD, FACS
MODERATOR
Vice Chairman
Department of Surgery
Attending Adult Cardiac Surgeon
Cedars-Sinai Medical Center
Los Angeles, CA

John G. Byrne, MD
William S. Stoney Professor and Chairman
Department of Cardiac Surgery
Vanderbilt Heart and Vascular Institute
Nashville, TN

Rahul Doshi, MD
Fullerton Cardiovascular Medical Group
Fullerton, CA

Mark A. Groh, MD
Cardiovascular and Thoracic Surgeon
Asheville Cardiovascular
& Thoracic Surgeons, PA
Asheville, NC

Michael R. Petracek, MD
Department of Cardiac Surgery
Vanderbilt University Medical Center
Nashville, TN

Mathew R. Williams, MD
Assistant Professor in Surgery and Medicine
Surgical Director, Cardiovascular Transcatheter Therapy
Columbia University
New York, NY

---

Agenda:

7:00pm – 7:30pm
Reception

7:30pm – 9:00pm
Dinner/Presentations

Heart Valve Disease: An Area of Growth
Minimally Invasive Approaches
Michael R. Petracek, MD

Transcatheter Valve Procedures and the Cardiac Surgeon
Gregory P. Fontana, MD, FACS

Atrial Fibrillation
Lone Therapy
Rahul Doshi, MD

Concomitant Therapy
Mark A. Groh, MD

Coronary Artery Disease: Hybrid Revascularization
Mathew R. Williams, MD,
and John G. Byrne, MD

---

Who Should Attend:
Physicians and allied professionals with an interest in treating atrial fibrillation, valvular disease, and myocardial ischemia

---

Learning Objectives:

Upon completion of this educational activity, participants should be able to:

• demonstrate that the cardiac surgeon and electrophysiologist can cooperate in providing collaborative care for patients with atrial fibrillation and that opportunities exist for both specialties
• demonstrate that the cardiac surgeon and interventional cardiologist can cooperate in providing collaborative care for patients with valvular disease and myocardial ischemia
• discuss the minimally invasive treatment options for heart valve disease
• describe advantages and disadvantages of the hybrid approach to complex valve and coronary disease
• explain the management of antiplatelet agents for hybrid patients.

---

Accreditation:

MD/DO: This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

Nurses: ANCC:NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1.5 contact hours (Provider Number 110-3-E-06). Provider approved by the California Board of Registered Nursing, Provider Number 13255, for 1.5 contact hours.

Technologists: Approved by The American Radiology Healthcare Administrators for 1.5 Category A, AART Credits.

---

Faculty Disclosure:

All those with control over the content of continuing education programs sponsored by NACCME are expected to disclose whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s). It is not assumed that these relationships will have an adverse impact on presentations. Full faculty disclosures will be presented at the meeting.

---

Commercial Supporter:

This activity is supported by an educational grant from St. Jude Medical.

---

This session is an industry-supported satellite symposium and is not an official part of the AATS Annual Meeting.

---

This activity is sponsored by the North American Center for Continuing Medical Education.

---